Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap6.87M
Enterprise Value4.01M
Can-Fite BioPharma Ltd.
CANFNYSEAMERICANHealthcareBiotechnology
$1.85Today:- (-)1Y −82.87%
As of Oct 15, 2026 close
- Market cap
- $6.87M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.90$12.30
- Volume (live)
- -
- Avg. volume (3M)
- 64.73K
Can-Fite BioPharma (CANF) Key Statistics & Financial Metrics
Complete stock analysis with 60+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Enterprise Value Ratios
EV-based valuation multiples
Stock Price
Current price, 52-week range, and moving averages
Current Price$1.85
1-Day Change−4.15%
52-Week High$12.30
52-Week Low$1.90
YTD Change−57.95%
1-Year Change−82.87%
50-Day MA$2.65
200-Day MA$3.35
Avg Volume (30 day)64.73K
Share Statistics
Outstanding shares, float, and per-share metrics
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin100.00%
EBITDA Margin (ttm)-2402.47%
EBIT Margin (ttm)-2456.79%
Operating Margin (ttm)-2402.96%
Pretax Margin (ttm)-2358.77%
Profit Margin (ttm)-2358.77%
FCF Margin (ttm)-2348.89%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)-196.77%
Return on Assets (ttm)-118.60%
Return on Invested Capital (ttm)-393.62%
Return on Capital Employed (ttm)-186.89%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue405.00K
Gross Profit405.00K
Operating Income-9.73M
Pretax Income-9.55M
Net Income-9.55M
EBITDA-9.73M
EBIT-9.95M
Diluted EPS−$0.06
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Efficiency Metrics
Asset Turnover0.05
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth−27.68%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Debt & Liabilities
Liabilities, debt, equity, and working capital
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-61.28
Source: Market prices and company fundamentals from financial filings. Data as of Oct 15, 2026. Data sources and methodology
Frequently Asked Questions About Can-Fite BioPharma Statistics
What are the key financial metrics for CANF?
Can-Fite BioPharma Ltd. (CANF) statistics include 60+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is CANF's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Can-Fite BioPharma is overvalued or undervalued.
How do I read CANF's profitability ratios?
Can-Fite BioPharma's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do CANF's debt ratios indicate?
The financial health section shows Can-Fite BioPharma's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is CANF's dividend analysis?
The dividend section covers Can-Fite BioPharma's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.